STOCK TITAN

Schrodinger (SDGR) executive receives new RSUs and stock option grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Schrodinger, Inc. executive Robert Lorne Abel reported equity awards that increase his direct holdings. He received a stock option covering 34,250 shares, granted at an exercise price of $0.00 per share, scheduled to vest 25% on March 2, 2027 and monthly through March 2, 2030, subject to continued service.

He also acquired 17,130 restricted stock units (RSUs) that vest in four equal installments on March 9 of 2027, 2028, 2029 and 2030, and 20,682 performance-based RSUs tied to previously granted awards for which performance achievement was certified on March 2, 2026. These PRSUs are scheduled to vest upon the filing of the company’s Form 10-K for the year ended December 31, 2026, subject to continued service. Following these awards, his direct holdings include an aggregate of 52,949 unvested RSUs.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Abel Robert Lorne

(Last) (First) (Middle)
C/O SCHRODINGER, INC.,
1540 BROADWAY, 24TH FLOOR

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Schrodinger, Inc. [ SDGR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 03/02/2026 A 17,130 A $0 36,515 D
Common Stock 03/02/2026 A(2) 20,682 A $0 57,197(3) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $12.15 03/02/2026 A 34,250 (4) 03/02/2036 Common Stock 34,250 $0 34,250 D
Explanation of Responses:
1. Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 2, 2026 and will vest in equal installments on each of March 9, 2027, 2028, 2029 and 2030, subject to the reporting person's continued service with the company.
2. Represents portion of the performance-based restricted stock units ("PRSUs") previously granted to the reporting person on March 4, 2024 and March 21, 2024, for which the compensation committee of the Issuer's board of directors certified on March 2, 2026 the level of achievement of the performance metrics for the PRSUs. The PRSUs will vest upon the filing of the Issuer's Annual Report on Form 10-K for the year ended December 31, 2026, subject to the reporting person's continued service with the company.
3. Includes an aggregate of 52,949 unvested RSUs.
4. The option was granted on March 2, 2026. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 2, 2027 and the remainder are scheduled to vest in equal monthly installments through March 2, 2030, subject to the reporting person's continued service with the company.
Remarks:
EVP, Chief Scientific Officer, Platform
/s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel 03/03/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Schrodinger (SDGR) executive Robert Lorne Abel receive?

Robert Lorne Abel received a stock option for 34,250 shares and restricted stock awards totaling 37,812 shares. These include 17,130 new time-based RSUs and 20,682 performance-based RSUs tied to previously granted awards with certified performance achievement.

How do the new stock options for Schrodinger (SDGR) executive vest?

The 34,250-share stock option granted to Robert Lorne Abel vests 25% on March 2, 2027, with the remaining 75% vesting in equal monthly installments through March 2, 2030. All vesting is conditioned on his continued service with the company throughout those periods.

What are the terms of the new RSU grant to Schrodinger (SDGR) executive Abel?

Abel’s 17,130 new RSUs were granted under Schrodinger’s 2022 Equity Incentive Plan. Each RSU represents one share of common stock and will vest in four equal installments on March 9, 2027, 2028, 2029 and 2030, assuming he continues serving the company.

How are Schrodinger (SDGR) performance-based RSUs vesting for executive Robert Lorne Abel?

Abel has 20,682 performance-based RSUs from 2024 grants whose performance metrics were certified on March 2, 2026. These PRSUs are scheduled to vest upon the filing of Schrodinger’s Form 10-K for the year ended December 31, 2026, subject to his continued service.

How many unvested RSUs does Schrodinger (SDGR) executive Abel now hold?

After the reported transactions, Abel’s holdings include an aggregate of 52,949 unvested RSUs. These consist of time-based and performance-based restricted stock units, each subject to specified vesting schedules and his continued employment or service with Schrodinger, Inc.
Schrodinger, Inc.

NASDAQ:SDGR

SDGR Rankings

SDGR Latest News

SDGR Latest SEC Filings

SDGR Stock Data

895.03M
62.58M
Health Information Services
Pharmaceutical Preparations
Link
United States
NEW YORK